Micioni Di Bonaventura Maria Vittoria, Ciccocioppo Roberto, Romano Adele, Bossert Jennifer M, Rice Kenner C, Ubaldi Massimo, St Laurent Robyn, Gaetani Silvana, Massi Maurizio, Shaham Yavin, Cifani Carlo
School of Pharmacy, Pharmacology Unit, University of Camerino, I-62032 Camerino, Italy.
Department of Physiology and Pharmacology, Sapienza University of Rome, I-00185 Rome, Italy, and.
J Neurosci. 2014 Aug 20;34(34):11316-24. doi: 10.1523/JNEUROSCI.1854-14.2014.
We developed recently a binge-eating model in which female rats with a history of intermittent food restriction show binge-like palatable food consumption after 15 min exposure to the sight of the palatable food. This "frustration stress" manipulation also activates the hypothalamic-pituitary-adrenal stress axis. Here, we determined the role of the stress neurohormone corticotropin-releasing factor (CRF) in stress-induced binge eating in our model. We also assessed the role of CRF receptors in the bed nucleus of the stria terminalis (BNST), a brain region implicated in stress responses and stress-induced drug seeking, in stress-induced binge eating. We used four groups that were first exposed or not exposed to repeated intermittent cycles of regular chow food restriction during which they were also given intermittent access to high-caloric palatable food. On the test day, we either exposed or did not expose the rats to the sight of the palatable food for 15 min (frustration stress) before assessing food consumption for 2 h. We found that systemic injections of the CRF1 receptor antagonist R121919 (2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7 dipropylamino pyrazolo[1,5-a]pyrimidine) (10-20 mg/kg) and BNST (25-50 ng/side) or ventricular (1000 ng) injections of the nonselective CRF receptor antagonist D-Phe-CRF(12-41) decreased frustration stress-induced binge eating in rats with a history of food restriction. Frustration stress also increased Fos (a neuronal activity marker) expression in ventral and dorsal BNST. Results demonstrate a critical role of CRF receptors in BNST in stress-induced binge eating in our rat model. CRF1 receptor antagonists may represent a novel pharmacological treatment for bingeing-related eating disorders.
我们最近建立了一种暴饮暴食模型,在该模型中,有间歇性食物限制史的雌性大鼠在看到美味食物15分钟后会出现类似暴饮暴食的美味食物摄入行为。这种“挫折应激”操作还会激活下丘脑-垂体-肾上腺应激轴。在此,我们确定了应激神经激素促肾上腺皮质激素释放因子(CRF)在我们模型中应激诱导的暴饮暴食中的作用。我们还评估了终纹床核(BNST)中的CRF受体在应激诱导的暴饮暴食中的作用,BNST是一个与应激反应和应激诱导的药物寻求有关的脑区。我们使用了四组大鼠,第一组先暴露或不暴露于重复的间歇性普通食物限制周期,在此期间它们也被间歇性给予高热量美味食物。在测试日,在评估2小时的食物摄入量之前,我们将大鼠暴露或不暴露于美味食物的视觉刺激15分钟(挫折应激)。我们发现,全身注射CRF1受体拮抗剂R121919(2,5-二甲基-3-(6-二甲基-4-甲基吡啶-3-基)-7-二丙基氨基吡唑并[1,5-a]嘧啶)(10-20毫克/千克)以及BNST局部注射(25-50纳克/侧)或脑室注射(1000纳克)非选择性CRF受体拮抗剂D-Phe-CRF(12-41)可减少有食物限制史的大鼠中挫折应激诱导的暴饮暴食。挫折应激还增加了腹侧和背侧BNST中Fos(一种神经元活动标记物)的表达。结果表明,BNST中的CRF受体在我们的大鼠模型中应激诱导的暴饮暴食中起关键作用。CRF1受体拮抗剂可能代表一种治疗与暴饮暴食相关的饮食失调的新型药物疗法。